List of works - Jing Tang

A Bayesian Predictive Model for Clustering Data of Mixed Discrete and Continuous Type.

scientific article

A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines

scientific article published on 3 October 2017

A community challenge for a pancancer drug mechanism of action inference from perturbational profile data

scientific article published on 18 January 2022

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

scientific article published on 17 March 2022

Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans

scientific article

Bayesian analysis of population structure based on linked molecular information

scientific article published on 28 September 2006

Bayesian clustering of fuzzy feature vectors using a quasi-likelihood approach

scientific article published in January 2009

Can We Assume the Gene Expression Profile as a Proxy for Signaling Network Activity?

scientific article published on 03 June 2020

Combined gene essentiality scoring improves the prediction of cancer dependency maps

scientific article published on 12 November 2019

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

scientific article published on 23 August 2016

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

scientific article published on 14 August 2017

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

scientific article

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer

scientific article published on 20 May 2019

DrugComb: an integrative cancer drug combination data portal

scientific article published on 01 July 2019

Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations

scientific article

From drug response profiling to target addiction scoring in cancer cell models

scientific article published on October 2015

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

Hyper-recombination, diversity, and antibiotic resistance in pneumococcus

scientific article published in June 2009

Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus

scientific article published on 25 February 2021

Identifying currents in the gene pool for bacterial populations using an integrative approach

scientific article

Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.

scientific article published on January 2017

Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.

scientific article published on 30 March 2009

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

scientific article

Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiency†

scientific article published on 01 April 2019

Making Sense of the Epigenome Using Data Integration Approaches

scientific article published on 19 February 2019

Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis

scientific article

Metabolome in schizophrenia and other psychotic disorders: a general population-based study

scientific article

Methods for High-throughput Drug Combination Screening and Synergy Scoring.

scientific article published in January 2018

Mining drug–target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model

scientific article published in 2024

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematological cells that are retained in corresponding malignant cell types

scientific article published on 22 August 2019

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles ⬇️

scientific article published on January 1, 2014

Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products

scientific article published on July 2015

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

scientific article published on 08 July 2019

Patient-customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.

scientific article published on 26 February 2018

Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia

scientific article published on 18 January 2012

Predicting Meridian in Chinese traditional medicine using machine learning approaches

scientific article published on 25 November 2019

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

scientific article published on 16 August 2021

Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model

scientific article published on 25 September 2015

Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells

scientific article published on June 2017

SynergyFinder: a web application for analyzing drug combination dose-response matrix data

scientific article

Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles.

scientific article published on 22 July 2015

Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells

scientific article published on 16 January 2017

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples

scientific article

Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways

scientific article

The ENDS of assumptions: an online tool for the epistemic non-parametric drug–response scoring

scientific article published in 2022

Toward more realistic drug-target interaction predictions

scientific article published on 9 April 2014

Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model

scientific article

Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation

scientific article published on 01 November 2021

What is synergy? The Saariselkä agreement revisited

scientific article

List of works by Jing Tang

A Bayesian Predictive Model for Clustering Data of Mixed Discrete and Continuous Type.

A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines

A community challenge for a pancancer drug mechanism of action inference from perturbational profile data

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans

Bayesian analysis of population structure based on linked molecular information

Bayesian clustering of fuzzy feature vectors using a quasi-likelihood approach

Can We Assume the Gene Expression Profile as a Proxy for Signaling Network Activity?

Combined gene essentiality scoring improves the prediction of cancer dependency maps

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer

DrugComb: an integrative cancer drug combination data portal

Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations

From drug response profiling to target addiction scoring in cancer cell models

Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol

Hyper-recombination, diversity, and antibiotic resistance in pneumococcus

Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus

Identifying currents in the gene pool for bacterial populations using an integrative approach

Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations.

Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiency†

Making Sense of the Epigenome Using Data Integration Approaches

Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis

Metabolome in schizophrenia and other psychotic disorders: a general population-based study

Methods for High-throughput Drug Combination Screening and Synergy Scoring.

Mining drug–target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematological cells that are retained in corresponding malignant cell types

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles ⬇️

Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

Patient-customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.

Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia

Predicting Meridian in Chinese traditional medicine using machine learning approaches

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model

Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells

SynergyFinder: a web application for analyzing drug combination dose-response matrix data

Systematic Mapping of Kinase Addiction Combinations in Breast Cancer Cells by Integrating Drug Sensitivity and Selectivity Profiles.

Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples

Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways

The ENDS of assumptions: an online tool for the epistemic non-parametric drug–response scoring

Toward more realistic drug-target interaction predictions

Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model

Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation

What is synergy? The Saariselkä agreement revisited